Digital technologies offer museums new opportunities for collecting and conveying information. Researchers at the University of Basel are initiating these types of projects and giving historical objects and museum holdings a second home online.
Twisted molecules play an important role in the development of organic light-emitting diodes. A team of chemists has managed to create these compounds with exactly the three-dimensional structure that they wanted. In so doing, they are smoothing the path for new and better light sources.
In advanced breast cancer, treatment often fails when the cancer cells become resistant to it. Researchers in Basel have now uncovered one mechanism behind this and found a possible solution to the problem: treatment in combination with a known antioxidant that is often used as an expectorant.
A research team at the University of Basel has discovered that a high-fat diet alters the function of adipose tissue, thus impairing its ability to regulate blood sugar. This explains why a high-fat diet poses a significant health risk, particularly for diabetes.
Light particles, also called photons, do not normally interact with each other. An international research team has now demonstrated for the first time that a few photons can be manipulated and made to interact in a controlled manner. This could advance both medical imaging and quantum computing.
Georg Rauter develops micro robots as tools for brain surgeons and dentists, and for operations on bones. He wants to establish Basel as a hub for medical robotics thanks to his collaborations with researchers in Switzerland and around the world.
When it comes to chronic infections and cancer, a particular type of immune cell plays a central role in our defenses. Researchers at the University of Basel have uncovered the key to the tenacity of these immune cells in coping with the marathon that is fighting a chronic infection. Their results lay the foundations for more effective therapies and vaccination strategies.
Remdesivir was one of the first medications approved for treatment of COVID-19. Clinical studies evaluated its effectiveness, but did not generate conclusive results. A new analysis of the study data shows that a specific group of patients benefits the most from the drug.
The autoimmune disease multiple sclerosis can take a variety of courses. Determining the current and future progression of the disease is important in order to slow down its course as much as possible. Researchers at the University of Basel have presented a biomarker whose values in the blood allow such predictions.
